Phase 3 Kidney Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been formally diagnosed with kidney cancer (renal cell carcinoma) of any subtype, confirmed through laboratory testing of tissue
• People who are 18 years of age or older
• People whose general physical health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scoring system called the ECOG scale (scores 0–2, meaning fully active to capable of self-care but limited in physical work)
• People whose scans show cancer has spread to distant parts of the body, but with no more than 5 separate areas of spread, as measured by standard imaging guidelines
• People who have already had treatment directed at the original (primary) kidney tumour site, such as surgery, a focused type of radiation, or ablation (a procedure that destroys tumour tissue)
• People who have received no more than 2 rounds of drug-based (systemic) treatment for their cancer
• People whose blood and organ function results fall within acceptable ranges, including blood cell counts, liver function, and blood clotting (confirm specific values with the trial site)

Who may not be able to join:

• People who have cancer that has spread to the brain
• People whose target tumour areas have previously received a high dose of radiation therapy (confirm with trial site)
• People whose target tumour areas are considered unsuitable for radiation therapy by the treating radiation specialist — for example, if the tumour is growing into the digestive tract or airways
• People with fluid build-up around the lungs or in the abdomen that cannot be controlled
• People who have another active cancer that has not been cured
• People with a significant history of psychiatric conditions that may affect their ability to understand and follow the study requirements
• People with other serious illnesses that could create significant health risks or interfere with radiation treatment
• Women who are pregnant, breastfeeding, or who plan to become pregnant during the study period
• People who the trial investigators consider unsuitable for the study for any other reason

Important: Always verify eligibility with the trial site directly before applying.